Top compounds associated with response to PCDHA3


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.001
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.001
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.001
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.13 0.002
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA paclitaxel UHNBreast pan-cancer AAC -0.8 0.002
mRNA pac-1 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA DBeQ CTRPv2 pan-cancer AAC 0.13 0.002
mRNA QW-BI-011 CTRPv2 pan-cancer AAC 0.22 0.002
Download CSV